ViroPharma Incorporated Swings to Q1 Loss on Charge, Higher Expenses

Bookmark and Share

Reuters -- Biopharmaceutical company ViroPharma Inc swung to a first-quarter loss, hurt mainly by charges and higher expenses.

MORE ON THIS TOPIC